FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition has agent showing antiviral activity with respect to herpes viruses 1 and 2 types. This agent is mussel hydrolysate prepared of meat of marine mollusk mussel (Mytilidae family) taken in the amount 8.4-25.2 mg (by dry matter) per 1 g of composition and pharmaceutically acceptable carrier. Composition does not show topical adverse effect and formation of resistant herpes virus strains. EFFECT: improved properties of composition. 7 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITING INFLUENZA VIRUS OF SEROTYPE A AND B | 1992 |
|
RU2043109C1 |
| ANTIVIRAL IMMUNOMODULATING AGENT | 2001 |
|
RU2202547C2 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| 4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 |
|
RU2573977C9 |
| METHOD FOR ASSESSING ANTI-HERPETIC EFFICACY in vitro OF PHOTODYNAMIC EXPOSURE ON HERPES SIMPLEX VIRUS (HSV) | 2013 |
|
RU2529792C1 |
| USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
| METHOD FOR VIRAL INFECTION CONTROL | 2019 |
|
RU2749968C2 |
| ANTIVIRAL COMPOUND OF MULTIPLE ACTION, ITS COMPOSITION AND METHOD OF TREATING VIRAL DISEASES | 2012 |
|
RU2597150C2 |
| INHIBITOR OF HERPES SIMPLEX VIRUS | 1991 |
|
RU2012335C1 |
| AGENT SHOWING EFFECT WITH RESPECT TO INFECTIOUS AGENTS | 1994 |
|
RU2092177C1 |
